SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Aurobindo Pharma Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524804 INE406A01037 318.5455537 AUROPHARMA 0.65 67,526.49 34.34 33.56 1
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales2663.872648.412363.53
Other Operating Income28.1620.3527.29
Other Income 331.13103.17112.83
Total Income3023.162771.932503.65
Total Expenditure 2210.342123.581968.44
PBIDT812.82648.35535.21
Interest 61.2536.6931.59
PBDT751.57611.66503.62
Depreciation64.3565.7959.63
Tax136.95137.17116.30
Fringe Benefit Tax0.000.000.00
Deferred Tax-73.51-7.04-8.26
Reported Profit After Tax623.78415.74335.95
Extra-ordinary Items 0.0036.0917.95
Adjusted Profit After Extra-ordinary item623.78379.65318.00
    
EPS (Unit Curr.)10.657.105.74
EPS (Adj) (Unit Curr.)10.657.105.74
Calculated EPS (Unit Curr.)10.657.105.73
Calculated EPS (Adj) (Unit Curr.)10.657.105.73
Calculated EPS (Ann.) (Unit Curr.)42.5928.3822.94
Calculated EPS (Adj) (Ann.) (Unit Curr.)42.5928.3822.94
Book Value (Unit Curr.)0.000.000.00
Dividend (%)150.000.000.00
Equity58.5958.5958.59
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)30.5124.4822.64
PBDTM(%)28.2123.1021.31
PATM(%)23.4215.7014.21